Cargando…

TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study

The DNA double strand break repair gene TOPBP1 has been suggested as a breast cancer susceptibility gene and a missense variant Arg309Cys was observed at elevated frequency in familial breast cancer cases compared to healthy controls from Finland. We found the Arg309Cys allele at a 13% carrier frequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Blaut, Magda A, Bogdanova, Natalia V, Bremer, Michael, Karstens, Johann H, Hillemanns, Peter, Dörk, Thilo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002300/
https://www.ncbi.nlm.nih.gov/pubmed/21108795
http://dx.doi.org/10.1186/1477-5751-9-9
_version_ 1782193725583130624
author Blaut, Magda A
Bogdanova, Natalia V
Bremer, Michael
Karstens, Johann H
Hillemanns, Peter
Dörk, Thilo
author_facet Blaut, Magda A
Bogdanova, Natalia V
Bremer, Michael
Karstens, Johann H
Hillemanns, Peter
Dörk, Thilo
author_sort Blaut, Magda A
collection PubMed
description The DNA double strand break repair gene TOPBP1 has been suggested as a breast cancer susceptibility gene and a missense variant Arg309Cys was observed at elevated frequency in familial breast cancer cases compared to healthy controls from Finland. We found the Arg309Cys allele at a 13% carrier frequency in a hospital-based series of 1064 German breast cancer patients and at a 14% carrier frequency in 1014 population controls (OR 0.89, 95%CI 0.69-1.15; p = 0.4). Arg309Cys carriers were not enriched among patients with a family history of breast cancer (OR = 0.87, 95%CI 0.53-1.43, p = 0.6) and were slightly underrepresented in patients with bilateral disease (OR = 0.49, 95%CI = 0.24-0.99; p = 0.047). In the latter group, the mean age at diagnosis was 62 years in carriers and 54 years in non-carriers (p = 0.004). We conclude that there is no evidence for the TOPBP1*Arg309Cys variant to confer an increased risk for breast cancer in the German population.
format Text
id pubmed-3002300
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30023002010-12-16 TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study Blaut, Magda A Bogdanova, Natalia V Bremer, Michael Karstens, Johann H Hillemanns, Peter Dörk, Thilo J Negat Results Biomed Brief Report The DNA double strand break repair gene TOPBP1 has been suggested as a breast cancer susceptibility gene and a missense variant Arg309Cys was observed at elevated frequency in familial breast cancer cases compared to healthy controls from Finland. We found the Arg309Cys allele at a 13% carrier frequency in a hospital-based series of 1064 German breast cancer patients and at a 14% carrier frequency in 1014 population controls (OR 0.89, 95%CI 0.69-1.15; p = 0.4). Arg309Cys carriers were not enriched among patients with a family history of breast cancer (OR = 0.87, 95%CI 0.53-1.43, p = 0.6) and were slightly underrepresented in patients with bilateral disease (OR = 0.49, 95%CI = 0.24-0.99; p = 0.047). In the latter group, the mean age at diagnosis was 62 years in carriers and 54 years in non-carriers (p = 0.004). We conclude that there is no evidence for the TOPBP1*Arg309Cys variant to confer an increased risk for breast cancer in the German population. BioMed Central 2010-11-25 /pmc/articles/PMC3002300/ /pubmed/21108795 http://dx.doi.org/10.1186/1477-5751-9-9 Text en Copyright ©2010 Blaut et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Report
Blaut, Magda A
Bogdanova, Natalia V
Bremer, Michael
Karstens, Johann H
Hillemanns, Peter
Dörk, Thilo
TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study
title TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study
title_full TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study
title_fullStr TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study
title_full_unstemmed TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study
title_short TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study
title_sort topbp1 missense variant arg309cys and breast cancer in a german hospital-based case-control study
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002300/
https://www.ncbi.nlm.nih.gov/pubmed/21108795
http://dx.doi.org/10.1186/1477-5751-9-9
work_keys_str_mv AT blautmagdaa topbp1missensevariantarg309cysandbreastcancerinagermanhospitalbasedcasecontrolstudy
AT bogdanovanataliav topbp1missensevariantarg309cysandbreastcancerinagermanhospitalbasedcasecontrolstudy
AT bremermichael topbp1missensevariantarg309cysandbreastcancerinagermanhospitalbasedcasecontrolstudy
AT karstensjohannh topbp1missensevariantarg309cysandbreastcancerinagermanhospitalbasedcasecontrolstudy
AT hillemannspeter topbp1missensevariantarg309cysandbreastcancerinagermanhospitalbasedcasecontrolstudy
AT dorkthilo topbp1missensevariantarg309cysandbreastcancerinagermanhospitalbasedcasecontrolstudy